Format

Send to

Choose Destination
Future Oncol. 2017 Jun;13(15):1291-1295. doi: 10.2217/fon-2017-0088. Epub 2017 Jun 26.

Highlights of the San Antonio Breast Cancer Symposium 2016.

Author information

1
Cambridge Breast Unit, Addenbrookes Hospital & University of Cambridge, Faculty of Medical Sciences, Anglia Ruskin University, Cambridge, UK.
2
Division of Surgical Oncology, Dale H Dorn Chair in Surgery, University of Texas Health Science Centre, TX, USA.

Abstract

The 39th annual San Antonio Breast Cancer Symposium (SABCS) was convened in San Antonio, Texas, on 9-13 December 2016. More than 7000 clinicians and scientists from around the world participated in the symposium which featured a range of presentations and keynote talks pertaining to breast cancer screening, prevention, locoregional and systemic therapies. This two-part report highlights a selection of important studies presented at this premier breast cancer event with Part 1 focusing onmetastatic breast cancer, extended endocrine therapy and the prognostic significance of BRCA1/2 gene mutations. The second part of this report will discuss a range of topics including anti-HER2 directed treatments, the impact of radiotherapy on implant and autologous flap based reconstruction, biological risk predictors for ductal carcinoma-in situ (DCIS), longer term effects of dietary fat modification and the influence of aromatase inhibitors on endothelial cell function.

KEYWORDS:

Breast conserving surgery; San Antonio; extended endocrine; mastectomy; radiation treatment; reconstruction

PMID:
28650276
DOI:
10.2217/fon-2017-0088
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center